Givant–Horwitz and collaborators found lower itga6 mRNA expression in FIGO stage IV ovarian cancer solid tumors compared to stage III ovarian cancer, which was correlated with shorter overall survival [133]. This evidence concerns the gene ITGA6 and ovarian carcinoma.